SCHEMBL20078747

SCHEMBL20078747

Cc1ccc(S(=O)(=O)NC2CC2)cc1C

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.87
SMN1; SMN2 Q16637 2/20 0.60
KMT2A Q03164 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
GAA P10253 1/20 0.60
KDM4E B2RXH2 2/20 0.56
RECQL P46063 1/20 0.56
CYP3A4 P08684 1/20 0.56
TSHR P16473 1/20 0.56
PARG Q86W56 1/20 0.55
LMNA P02545 2/20 0.55
MAPT P10636 1/20 0.55
MAPK1 P28482 1/20 0.55
CACNA1B Q00975 1/20 0.55
APBA1 Q02410 1/20 0.55
HTT P42858 1/20 0.55
PDE4A P27815 1/20 0.53
PDE4B Q07343 1/20 0.53
PDE4C Q08493 1/20 0.53
PDE4D Q08499 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23052294 0.85 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2KMT2ATDP1GAA
SCHEMBL14419472 0.85 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2KMT2ATDP1GAA
SCHEMBL2372122 0.85 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2KMT2ATDP1GAA
SCHEMBL29956105 0.82 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2KMT2ATDP1GAA
SCHEMBL16195567 0.82 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2KMT2ATDP1GAA
SCHEMBL20078764 0.80 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2KMT2ATDP1GAA
SCHEMBL2372546 0.79 ALDH1A1 (0.83) ALDH1A1SMN1; SMN2KMT2ATDP1GAA
SCHEMBL17205857 0.79 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2KMT2ATDP1GAA
SCHEMBL17205858 0.79 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2KMT2ATDP1GAA
SCHEMBL14419470 0.79 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2KMT2ATDP1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9949955-B2 Triazolone compounds as mPGES-1 inhibitors GLENMARK PHARMACEUTICALS S.A. (CH) 2018-04-24 US disclosed